Stocks to Watch, 05 May: Stocks like Avenue Supermarts, Vardhman Textiles, Voltamp Transformers, PNB Gilts, Archean Chemical Industries, Sanofi Consumer Healthcare India, Gravita India, Sunteck Realty, City Union Bank, Aether Industries, Shilpa Medicare, BSE, GOCL Corporation, Tata Motors, Indraprastha Gas, and Tata Steel will be in focus on May 5.
Stocks to Watch, 9 Apr: Stocks like Shyam Metalics and Energy, Swan Defence and Heavy Industries, Vodafone Idea, NTPC, Karnataka Bank, PNB Housing Finance, Hindustan Aeronautics, Stallion India Fluorochemicals, Route Mobile, GAIL India, NTPC Green Energy, and Sonata Software will be in focus on April 9.
Concord Biotech reported that its consolidated net profit declined 2.19 percent to Rs 75.9 crore in the December 2024 quarter.
The bullish sentiment is expected to sustain with the VIX reaching a one-month low. Below are some trading ideas for the near term.
The market is expected to consolidate until it gets back above all key moving averages. Below are some trading ideas for the near term.
Overall, the trend remains in favour of bears, given the negative bias in momentum indicators and indices trading below all key moving averages. Below are some trading ideas for the near term.
The consolidation is expected to continue as long as the frontline indices trade below all key moving averages. Below are some trading ideas for the near term.
Buy Nifty Futures between 24,200-24,225, with a stop-loss of 24,050, targeting 24,500, while buy Bank Nifty Futures with a stop-loss of 52,200-52,250, with a stop-loss of 51,800, targeting 53,000.
Though valuations are at a premium, the company has strong earnings prospects ahead
The ongoing exploration of opportunities in the Contract Development and Manufacturing Organization (CDMO) segment is anticipated to accelerate growth for Concord Biotech, according to Choice Broking.
After an impressive 220 bps EBITDA margin expansion in FY24, Concord is guiding for further improvement in FY25/26.
As per reports, the residual stake held by Ontario Inc post the block deal could be locked in for a period of 90 days before the firms could pare any further equity. Ontario Inc held a 5.39 percent stake in Concord Biotech as of the March quarter.
The seller entity will have residual stake of two percent in the company after the transaction
Concord Biotech Consolidated December 2023
This leading fermentation play on APIs is a worthy watch, given the scope for a ramp-up in new facilities, foray into injectables and a strong balance sheet.
